Document is current
Any future updates will be listed below
-
Authors
Lieschke, Franziska
Gelhard, Sarah
Rosenthal-Rueckeis, Michelle
Grefkes, Christian
Bohmann, Ferdinand O. https://orcid.org/0000-0001-6439-0667
-
Funding
Funding for this research was provided by:
Alexion Pharmaceuticals
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 17 May 2025
Accepted: 28 January 2026
First Online: 3 March 2026
Declarations
:
: Franziska Lieschke reports speakers’ honoraria from Laerdal. Ferdinand Bohmann reports speakers’ honoraria from Laerdal, AstraZeneca, Bristol-Myers-Squibb, Pfizer, Medtronic and grants and personal fees from Alexion, Stryker Neurovascular, Boehringer Ingelheim. All other authors have nothing to declare.
: All animal experiments were prospectively approved by the research ethics committee and continuously monitored (Regierungspraesidium Darmstadt, approval number FU/2054).
